The methylation and subsequent degradation of EZH2 by the methyltransferase SETD2, was recently shown to block metastasis in PCa, further suggesting that EZH2 inhibition in PCa could be of therapeutic advantage (123). This evidence concerns the gene SETD2 and posterior cortical atrophy.